12
Oct
The development of a safe and effective dengue vaccine is a high priority and WHO supports this effort through technical guidance and advice. Barniol J Gaczkowski R Barbato EV da Cunha RV Salgado D Martinez E et al 2011 Usefulness and applicability of the revised dengue case classification by disease.
SEARO Technical Publication Series No.
Who dengue guidelines 2011. Comprehensive Guideline for Prevention and Control of Dengue and Dengue Haemorrhagic Fever. Revised and expanded edition. WHO Regional Office for South-East Asia.
Activities undertaken by WHO regarding dengue are most recently guided at the global policy level by World Health Assembly resolution WHA5517 adopted by the Fifty-fifth World Health Assembly in 2002 and at the regional level by resolution CE140R17 of the Pan American Sanitary Conference 2007 resolution WPRRC59R6 of the WHO Regional Committee for the Western Pacific 2008 and. WHO 2011 Guideline of Dengue Infection 2 Motz Gaming. Download Full PDF Package.
A short summary of this paper. 37 Full PDFs related to this paper. WHO 2011 Guideline of Dengue Infection 2 Download.
WHO 2011 Guideline of Dengue Infection 2. This revised and expanded edition of the Comprehensive Guidelines is intended to provide guidance to national and local-level programme managers and public health officials of Member States as well as other stakeholders including health practitioners laboratory personnel and multisectoral partners on strategic planning implementation monitoring and evaluation and strengthening the response to dengue. Guidelines on the quality safety and efficacy of dengue tetravalent vaccines live attenuated were adopted by ECBS in 2011.
Guidelines on the quality safety and efficacy of dengue tetravalent vaccines live attenuated. Annex 2 Technical Report Series No. Additional and more specific guidance on the various areas related to clinical management of dengue from other sources in WHO and elsewhere are cited in the reference sections.
This handbook is not intended to replace national treatment training materials and guidelines but it aims to assist in the development of such materials produced at local national or regional level. WHO recommends that countries should consider introduction of the dengue vaccine CYD-TDV only in geographic settings national or subnational where epidemiological data indicate a high burden of disease. The development of a safe and effective dengue vaccine is a high priority and WHO supports this effort through technical guidance and advice.
Guidelines for diagnosis treatment prevention and control METHODOLOGY These guidelines were written using the following methodology. Writing team Each chapter was allocated to a WHO coordinator and at least one non-WHO lead writer. The non-WHO lead writers received a small fee for their work.
Comprehensive guidelines for prevention and control of dengue and dengue haemorrhagic fever. Revised and expanded edition. SEARO Technical Publication Series No.
Undifferentiated fever Those who have been infected with dengue virus especially for the first time i e. Dengue Guidelines for Diagnosis Treatment Prevention and Control New edition 2009WHO Geneva66. Collection storage and shipment.
An essential aspect of. Guidelines for the Prevention and Control of DFDHF. Since then new strategies and developments in the control of dengue fever DHF and DSS have come to light.
The Regional Guidelines were extensively revised updated and expanded with the focus on new and additional topics of current relevance to the populations of Member States of the Region. REVISED DENGUE CLINICAL CASE MANAGEMENT GUIDELINES 2011 I. BACKGROUND and RATIONALE According to WHO dengue is the most rapidly spreading mosquito-borne viral disease in the world.
In the last 50 years incidence has increased 30-fold with increasing geographic expansion to new countries and in the. World Health Organization 2009 Dengue. Guidelines for diagnosis treatment prevention and control.
Barniol J Gaczkowski R Barbato EV da Cunha RV Salgado D Martinez E et al 2011 Usefulness and applicability of the revised dengue case classification by disease. Multi-centre study in 18 countries. Dengue fever DF is an acute febrile viral disease frequently presenting with headaches bone or joint and muscular pains rash and leukopenia as symp-toms.
Dengue haemorrhagic fever DHF is characterized by four major clin-ical manifestations. Comprehensive guidelines for prevention and control of dengue and dengue haemorrhagic fever - revised and expanded edition. Comprehensive guidelines for prevention and control of dengue and Dengue Haemorrhagic Fever.
Revised and expanded edition. S EARO Technical Publication Series No. 60 2011 Unusual Dengue Expanded Dengue Syndrome - please see page 32 1 Asymptomatic Symptomatic Undifferentiated fever Viral Syndrome DF DHF Expanded dengue syndrome.
Testing for dengue is recommended in persons who have a clinically compatible illness and have travelled to an area with known dengue activity during the.